RD
Richard Douglas

Richard Douglas insider trades: Aldeyra Therapeutics (ALDX) stock purchases

Aldeyra Therapeutics Last trade Mar 19, 2026 58 Form 4 filings
$0
Sold, last 12 months
0 sales
$98K
Bought, last 12 months
1 buy
16
Open-market trades
since 2011
4
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Richard reports to the SEC

Open-market buys and sales

16 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 19, 2026ALDX↑ Buy$98K
Aug 13, 2025MXCT↑ Buy$111K
Mar 29, 2023MXCT↑ Buy$345K
Nov 22, 2021MXCT↑ Buy$222K
Mar 16, 2020ALDX↑ Buy$110K
Sep 13, 2019ALDX↑ Buy$30K
Sep 12, 2019ALDX↑ Buy$118K
Sep 10, 2019ALDX↑ Buy$100K
May 11, 2017NVAX↑ Buy$186K
Feb 17, 2017ALDX↑ Buy$180K
Sep 21, 2016NVAX↑ Buy$172K
Mar 25, 2014NVAX↑ Buy$217K
Jun 12, 2013NVAX↑ Buy$95K
Apr 10, 2012NVAX↑ Buy$61K
Aug 9, 2011NVAX↑ Buy$60K
Jun 20, 2011NVAX↑ Buy$102K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Richard Douglas's insider trades

Richard Douglas is an insider at Aldeyra Therapeutics (ALDX). Since Jun 20, 2011, Richard has reported 16 open-market purchases worth $2.2M and no sales on SEC Form 4. In the last 12 months: 1 buy ($98K).

Their filings also include grants and awards (36 filings), option exercises (8 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ALDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.